MLM Medical Labs Validates Lumipulse® G pTau217/Beta-Amyloid 1-42 Plasma Ratio Assay Under IVDR/LDT Framework
First central lab in EU to perform this blood-based assay under IVDR/LDT regulations, supporting inclusion and exclusion criteria in Alzheimer’s clinical trials MöNCHENGLADBACH, NORTH RHINE-WESTPHALIA, GERMANY, November 3, 2025 /EINPresswire.com/ -- MLM …